Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma

Massimo Martino, Roberto Massimo Lemoli, Corrado Girmenia, Luca Castagna, B. Bruno, Federica Cavallo, Massimo Offidani, Ilaria Scortechini, Mauro Montanari, G. Milone, Laura Postacchini, Attilio Olivieri

Research output: Contribution to journalArticle

Abstract

Multiple myeloma (MM) is the leading indication for autologous stem cell transplantation (ASCT) worldwide. The safety and efficacy of reducing hospital stay for MM patients undergoing ASCT have been widely explored, and different outpatient models have been proposed. However, there is no agreement on the criteria for selecting patients eligible for this strategy as well as the standards for their clinical management. On the basis of this rationale, the Italian Group for Stem Cell Transplantation (GITMO) endorsed a project to develop guidelines for the management of outpatient ASCT in MM, using evidence-based knowledge and consensus-formation techniques. An expert panel convened to discuss the currently available data on the practice of outpatient ASCT management and formulated recommendations according to the supporting evidence. Evidence gaps were filled with consensus-based statements. Three main topics were addressed: (1) the identification of criteria for selecting MM patients eligible for outpatient ASCT management; (2) the definition of standard procedures for performing outpatient ASCT (model, supportive care and monitoring during the aplastic phase); (3) the definition of the standard criteria and procedures for re-hospitalization during the aplastic phase at home. Herein, we report the summary and the results of the discussion and the consensus.Bone Marrow Transplantation advance online publication, 4 April 2016; doi:10.1038/bmt.2016.79.

Original languageEnglish
JournalBone Marrow Transplantation
DOIs
Publication statusAccepted/In press - Apr 4 2016

Fingerprint

Stem Cell Transplantation
Multiple Myeloma
Outpatients
Bone Marrow Transplantation
Publications
Length of Stay
Hospitalization
Guidelines
Safety

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma. / Martino, Massimo; Lemoli, Roberto Massimo; Girmenia, Corrado; Castagna, Luca; Bruno, B.; Cavallo, Federica; Offidani, Massimo; Scortechini, Ilaria; Montanari, Mauro; Milone, G.; Postacchini, Laura; Olivieri, Attilio.

In: Bone Marrow Transplantation, 04.04.2016.

Research output: Contribution to journalArticle

Martino, M, Lemoli, RM, Girmenia, C, Castagna, L, Bruno, B, Cavallo, F, Offidani, M, Scortechini, I, Montanari, M, Milone, G, Postacchini, L & Olivieri, A 2016, 'Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma', Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2016.79
Martino, Massimo ; Lemoli, Roberto Massimo ; Girmenia, Corrado ; Castagna, Luca ; Bruno, B. ; Cavallo, Federica ; Offidani, Massimo ; Scortechini, Ilaria ; Montanari, Mauro ; Milone, G. ; Postacchini, Laura ; Olivieri, Attilio. / Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma. In: Bone Marrow Transplantation. 2016.
@article{7f59baa9739b499da3e034ab6845ee34,
title = "Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma",
abstract = "Multiple myeloma (MM) is the leading indication for autologous stem cell transplantation (ASCT) worldwide. The safety and efficacy of reducing hospital stay for MM patients undergoing ASCT have been widely explored, and different outpatient models have been proposed. However, there is no agreement on the criteria for selecting patients eligible for this strategy as well as the standards for their clinical management. On the basis of this rationale, the Italian Group for Stem Cell Transplantation (GITMO) endorsed a project to develop guidelines for the management of outpatient ASCT in MM, using evidence-based knowledge and consensus-formation techniques. An expert panel convened to discuss the currently available data on the practice of outpatient ASCT management and formulated recommendations according to the supporting evidence. Evidence gaps were filled with consensus-based statements. Three main topics were addressed: (1) the identification of criteria for selecting MM patients eligible for outpatient ASCT management; (2) the definition of standard procedures for performing outpatient ASCT (model, supportive care and monitoring during the aplastic phase); (3) the definition of the standard criteria and procedures for re-hospitalization during the aplastic phase at home. Herein, we report the summary and the results of the discussion and the consensus.Bone Marrow Transplantation advance online publication, 4 April 2016; doi:10.1038/bmt.2016.79.",
author = "Massimo Martino and Lemoli, {Roberto Massimo} and Corrado Girmenia and Luca Castagna and B. Bruno and Federica Cavallo and Massimo Offidani and Ilaria Scortechini and Mauro Montanari and G. Milone and Laura Postacchini and Attilio Olivieri",
year = "2016",
month = "4",
day = "4",
doi = "10.1038/bmt.2016.79",
language = "English",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma

AU - Martino, Massimo

AU - Lemoli, Roberto Massimo

AU - Girmenia, Corrado

AU - Castagna, Luca

AU - Bruno, B.

AU - Cavallo, Federica

AU - Offidani, Massimo

AU - Scortechini, Ilaria

AU - Montanari, Mauro

AU - Milone, G.

AU - Postacchini, Laura

AU - Olivieri, Attilio

PY - 2016/4/4

Y1 - 2016/4/4

N2 - Multiple myeloma (MM) is the leading indication for autologous stem cell transplantation (ASCT) worldwide. The safety and efficacy of reducing hospital stay for MM patients undergoing ASCT have been widely explored, and different outpatient models have been proposed. However, there is no agreement on the criteria for selecting patients eligible for this strategy as well as the standards for their clinical management. On the basis of this rationale, the Italian Group for Stem Cell Transplantation (GITMO) endorsed a project to develop guidelines for the management of outpatient ASCT in MM, using evidence-based knowledge and consensus-formation techniques. An expert panel convened to discuss the currently available data on the practice of outpatient ASCT management and formulated recommendations according to the supporting evidence. Evidence gaps were filled with consensus-based statements. Three main topics were addressed: (1) the identification of criteria for selecting MM patients eligible for outpatient ASCT management; (2) the definition of standard procedures for performing outpatient ASCT (model, supportive care and monitoring during the aplastic phase); (3) the definition of the standard criteria and procedures for re-hospitalization during the aplastic phase at home. Herein, we report the summary and the results of the discussion and the consensus.Bone Marrow Transplantation advance online publication, 4 April 2016; doi:10.1038/bmt.2016.79.

AB - Multiple myeloma (MM) is the leading indication for autologous stem cell transplantation (ASCT) worldwide. The safety and efficacy of reducing hospital stay for MM patients undergoing ASCT have been widely explored, and different outpatient models have been proposed. However, there is no agreement on the criteria for selecting patients eligible for this strategy as well as the standards for their clinical management. On the basis of this rationale, the Italian Group for Stem Cell Transplantation (GITMO) endorsed a project to develop guidelines for the management of outpatient ASCT in MM, using evidence-based knowledge and consensus-formation techniques. An expert panel convened to discuss the currently available data on the practice of outpatient ASCT management and formulated recommendations according to the supporting evidence. Evidence gaps were filled with consensus-based statements. Three main topics were addressed: (1) the identification of criteria for selecting MM patients eligible for outpatient ASCT management; (2) the definition of standard procedures for performing outpatient ASCT (model, supportive care and monitoring during the aplastic phase); (3) the definition of the standard criteria and procedures for re-hospitalization during the aplastic phase at home. Herein, we report the summary and the results of the discussion and the consensus.Bone Marrow Transplantation advance online publication, 4 April 2016; doi:10.1038/bmt.2016.79.

UR - http://www.scopus.com/inward/record.url?scp=84962053942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962053942&partnerID=8YFLogxK

U2 - 10.1038/bmt.2016.79

DO - 10.1038/bmt.2016.79

M3 - Article

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -